348 related articles for article (PubMed ID: 19811822)
1. Vitamin D3-driven signals for myeloid cell differentiation--implications for differentiation therapy.
Hughes PJ; Marcinkowska E; Gocek E; Studzinski GP; Brown G
Leuk Res; 2010 May; 34(5):553-65. PubMed ID: 19811822
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D analogs, 20-Epi-22-oxa-24a,26a,27a,-trihomo-1alpha,25(OH)2-vitamin D3, 1,24(OH)2-22-ene-24-cyclopropyl-vitamin D3 and 1alpha,25(OH)2-lumisterol3 prime NB4 leukemia cells for monocytic differentiation via nongenomic signaling pathways, involving calcium and calpain.
Berry DM; Meckling-Gill KA
Endocrinology; 1999 Oct; 140(10):4779-88. PubMed ID: 10499538
[TBL] [Abstract][Full Text] [Related]
3. ERK 5/MAPK pathway has a major role in 1α,25-(OH)2 vitamin D3-induced terminal differentiation of myeloid leukemia cells.
Wang X; Pesakhov S; Weng A; Kafka M; Gocek E; Nguyen M; Harrison JS; Danilenko M; Studzinski GP
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():223-7. PubMed ID: 24514755
[TBL] [Abstract][Full Text] [Related]
4. Signaling of monocytic differentiation by a non-hypercalcemic analog of vitamin D3, 1,25(OH)2-5,6 trans-16-ene-vitamin D3, involves nuclear vitamin D receptor (nVDR) and non-nVDR-mediated pathways.
Ji Y; Wang X; Donnelly RJ; Uskokovic MR; Studzinski GP
J Cell Physiol; 2002 May; 191(2):198-207. PubMed ID: 12064463
[TBL] [Abstract][Full Text] [Related]
5. 1,25-Dihydroxyvitamin D
Kim Y; Kim HS; Sohn J; Ji JD
Biochem Biophys Res Commun; 2019 Nov; 519(4):909-915. PubMed ID: 31563324
[TBL] [Abstract][Full Text] [Related]
6. 1alpha,25-dihydroxy-24-oxo-16-ene vitamin D3, a metabolite of a synthetic vitamin D3 analog, 1alpha,25-dihydroxy-16-ene vitamin D3, is equipotent to its parent in modulating growth and differentiation of human leukemic cells.
Siu-Caldera ML; Clark JW; Santos-Moore A; Peleg S; Liu YY; Uskoković MR; Sharma S; Reddy GS
J Steroid Biochem Mol Biol; 1996 Dec; 59(5-6):405-12. PubMed ID: 9010346
[TBL] [Abstract][Full Text] [Related]
7. 1 alpha,25-dihydroxyvitamin D3 transrepresses retinoic acid transcriptional activity via vitamin D receptor in myeloid cells.
Bastie JN; Balitrand N; Guidez F; Guillemot I; Larghero J; Calabresse C; Chomienne C; Delva L
Mol Endocrinol; 2004 Nov; 18(11):2685-99. PubMed ID: 15284334
[TBL] [Abstract][Full Text] [Related]
8. Induction of macrophage differentiation of human normal and leukemic myeloid stem cells by 1,25-dihydroxyvitamin D3 and its fluorinated analogues.
Koeffler HP; Amatruda T; Ikekawa N; Kobayashi Y; DeLuca HF
Cancer Res; 1984 Dec; 44(12 Pt 1):5624-8. PubMed ID: 6594194
[TBL] [Abstract][Full Text] [Related]
9. Combination of 22-oxa-1,25-dihydroxyvitamin D(3), a vitamin D(3) derivative, with vitamin K(2) (VK2) synergistically enhances cell differentiation but suppresses VK2-inducing apoptosis in HL-60 cells.
Funato K; Miyazawa K; Yaguchi M; Gotoh A; Ohyashiki K
Leukemia; 2002 Aug; 16(8):1519-27. PubMed ID: 12145693
[TBL] [Abstract][Full Text] [Related]
10. 1,25-Dihydroxyvitamin D3: in vivo and in vitro effects on human preleukemic and leukemic cells.
Koeffler HP; Hirji K; Itri L
Cancer Treat Rep; 1985 Dec; 69(12):1399-407. PubMed ID: 2416438
[TBL] [Abstract][Full Text] [Related]
11. 1,25-Dihydroxycholecalciferol-induced differentiation of myelomonocytic leukemic cells unresponsive to colony stimulating factors and phorbol esters.
Bettens F; Schlick E; Farrar W; Ruscetti F
J Cell Physiol; 1986 Dec; 129(3):295-302. PubMed ID: 3491083
[TBL] [Abstract][Full Text] [Related]
12. Myeloid cell differentiation in response to calcitriol for expression CD11b and CD14 is regulated by myeloid zinc finger-1 protein downstream of phosphatidylinositol 3-kinase.
Moeenrezakhanlou A; Shephard L; Lam L; Reiner NE
J Leukoc Biol; 2008 Aug; 84(2):519-28. PubMed ID: 18495781
[TBL] [Abstract][Full Text] [Related]
13. Interplay between signalling pathways mediates 1,25alpha-dihydroxyvitamin D3-driven monocytic differentiation--JNKs are important.
Hughes PJ; Brown G
Leuk Res; 2009 Oct; 33(10):1298-300. PubMed ID: 19428105
[No Abstract] [Full Text] [Related]
14. Differentiation-inducing potency of the seco-steroid JK-1624F2-2 can be increased by combination with an antioxidant and a p38MAPK inhibitor which upregulates the JNK pathway.
Zhang J; Posner GH; Danilenko M; Studzinski GP
J Steroid Biochem Mol Biol; 2007; 105(1-5):140-9. PubMed ID: 17583492
[TBL] [Abstract][Full Text] [Related]
15. Anticoagulant effects of 1alpha,25-dihydroxyvitamin D3 on human myelogenous leukemia cells and monocytes.
Koyama T; Shibakura M; Ohsawa M; Kamiyama R; Hirosawa S
Blood; 1998 Jul; 92(1):160-7. PubMed ID: 9639512
[TBL] [Abstract][Full Text] [Related]
16. Antagonistic action of novel 1alpha,25-dihydroxyvitamin D3-26, 23-lactone analogs on differentiation of human leukemia cells (HL-60) induced by 1alpha,25-dihydroxyvitamin D3.
Miura D; Manabe K; Ozono K; Saito M; Gao Q; Norman AW; Ishizuka S
J Biol Chem; 1999 Jun; 274(23):16392-9. PubMed ID: 10347199
[TBL] [Abstract][Full Text] [Related]
17. Induction of a functional vitamin D receptor in all-trans-retinoic acid-induced monocytic differentiation of M2-type leukemic blast cells.
Manfredini R; Trevisan F; Grande A; Tagliafico E; Montanari M; Lemoli R; Visani G; Tura S; Ferrari S; Ferrari S
Cancer Res; 1999 Aug; 59(15):3803-11. PubMed ID: 10446999
[TBL] [Abstract][Full Text] [Related]
18. 1alpha,25-dihydroxyvitamin D(3) displays divergent growth effects in both normal and malignant cells.
Rashid SF; Mountford JC; Gombart AF; Campbell MJ
Steroids; 2001; 66(3-5):433-40. PubMed ID: 11179752
[TBL] [Abstract][Full Text] [Related]
19. A new series of vitamin D analogs is highly active for clonal inhibition, differentiation, and induction of WAF1 in myeloid leukemia.
Munker R; Kobayashi T; Elstner E; Norman AW; Uskokovic M; Zhang W; Andreeff M; Koeffler HP
Blood; 1996 Sep; 88(6):2201-9. PubMed ID: 8822940
[TBL] [Abstract][Full Text] [Related]
20. The synthetic triterpenoid CDDO-imidazolide induces monocytic differentiation by activating the Smad and ERK signaling pathways in HL60 leukemia cells.
Ji Y; Lee HJ; Goodman C; Uskokovic M; Liby K; Sporn M; Suh N
Mol Cancer Ther; 2006 Jun; 5(6):1452-8. PubMed ID: 16818503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]